Literature DB >> 18805793

Human T-cell leukemia virus type 1 HBZ protein bypasses the targeting function of ubiquitination.

Osamu Isono1, Takayuki Ohshima, Yasushi Saeki, Jun Matsumoto, Makoto Hijikata, Keiji Tanaka, Kunitada Shimotohno.   

Abstract

Human T-cell leukemia virus type 1 (HTLV-1) encodes an antisense viral gene product termed HTLV-1 basic leucine-zipper factor (HBZ). HBZ forms heterodimers with c-Jun, a member of the AP-1 family, and promotes its proteasomal degradation. Although most proteasomal substrates are targeted for degradation via conjugation of polyubiquitin chains, we show that ubiquitination is not required for HBZ-mediated proteasomal degradation of c-Jun. We demonstrate that HBZ directly interacts with both the 26 S proteasome and c-Jun and facilitates the delivery of c-Jun to the proteasome without ubiquitination. HBZ acts as a tethering factor between the 26 S proteasome and its substrate, thereby bypassing the targeting function of ubiquitination. These findings disclose a novel viral strategy to utilize the cellular proteolytic system for viral propagation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805793      PMCID: PMC2662237          DOI: 10.1074/jbc.M802527200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

Review 1.  Degradation of oxidized proteins by the 20S proteasome.

Authors:  K J Davies
Journal:  Biochimie       Date:  2001 Mar-Apr       Impact factor: 4.079

Review 2.  Ubiquitin-mediated proteolysis: biological regulation via destruction.

Authors:  A Ciechanover; A Orian; A L Schwartz
Journal:  Bioessays       Date:  2000-05       Impact factor: 4.345

3.  Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex.

Authors:  E Querido; P Blanchette; Q Yan; T Kamura; M Morrison; D Boivin; W G Kaelin; R C Conaway; J W Conaway; P E Branton
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

Review 4.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.

Authors:  Michael H Glickman; Aaron Ciechanover
Journal:  Physiol Rev       Date:  2002-04       Impact factor: 37.312

5.  A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome.

Authors:  R Touitou; J Richardson; S Bose; M Nakanishi; J Rivett; M J Allday
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

Review 6.  Multiple viral strategies of HTLV-1 for dysregulation of cell growth control.

Authors:  M Yoshida
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

Review 7.  AP-1 as a regulator of cell life and death.

Authors:  Eitan Shaulian; Michael Karin
Journal:  Nat Cell Biol       Date:  2002-05       Impact factor: 28.824

8.  Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.

Authors:  R J Sheaff; J D Singer; J Swanger; M Smitherman; J M Roberts; B E Clurman
Journal:  Mol Cell       Date:  2000-02       Impact factor: 17.970

9.  Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription.

Authors:  Isabelle Lemasson; Matthew R Lewis; Nicholas Polakowski; Patrick Hivin; Marie-Hélène Cavanagh; Sabine Thébault; Benoit Barbeau; Jennifer K Nyborg; Jean-Michel Mesnard
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

10.  Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.

Authors:  Gad Asher; Joseph Lotem; Leo Sachs; Chaim Kahana; Yosef Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-13       Impact factor: 11.205

View more
  19 in total

Review 1.  Molecular mechanisms of HTLV-1 infection and pathogenesis.

Authors:  Junichiro Yasunaga; Masao Matsuoka
Journal:  Int J Hematol       Date:  2011-09-28       Impact factor: 2.490

Review 2.  Human T-lymphotropic virus proteins and post-translational modification pathways.

Authors:  Carlo Bidoia
Journal:  World J Virol       Date:  2012-08-12

3.  Human T-cell leukemia virus type 1 (HTLV-1) bZIP factor requires cellular transcription factor JunD to upregulate HTLV-1 antisense transcription from the 3' long terminal repeat.

Authors:  Hélène Gazon; Isabelle Lemasson; Nicholas Polakowski; Raymond Césaire; Masao Matsuoka; Benoit Barbeau; Jean-Michel Mesnard; Jean-Marie Peloponese
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

4.  Human T-cell leukemia virus type 3 (HTLV-3) and HTLV-4 antisense-transcript-encoded proteins interact and transactivate Jun family-dependent transcription via their atypical bZIP motif.

Authors:  Émilie Larocque; Charlotte André-Arpin; Malgorzata Borowiak; Guy Lemay; William M Switzer; Madeleine Duc Dodon; Jean-Michel Mesnard; Benoit Barbeau
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

5.  cAMP response element-binding protein interacts with and stimulates the proteasomal degradation of the nuclear receptor coactivator GRIP1.

Authors:  Tuyen Hoang; Ingvild S Fenne; Andre Madsen; Olivera Bozickovic; Mona Johannessen; Mari Bergsvåg; Ernst Asbjørn Lien; Michael R Stallcup; Jørn V Sagen; Ugo Moens; Gunnar Mellgren
Journal:  Endocrinology       Date:  2013-03-05       Impact factor: 4.736

6.  The intrinsically disordered N-terminal domain of thymidylate synthase targets the enzyme to the ubiquitin-independent proteasomal degradation pathway.

Authors:  Maria Marjorette O Peña; Sandra P Melo; Yang-Yang Xing; Kenneth White; Karen W Barbour; Franklin G Berger
Journal:  J Biol Chem       Date:  2009-09-21       Impact factor: 5.157

7.  The splice 1 variant of HTLV-1 bZIP factor stabilizes c-Jun.

Authors:  Nicholas Polakowski; Martin Pearce; Oppah Kuguyo; Georgina Boateng; Kimson Hoang; Isabelle Lemasson
Journal:  Virology       Date:  2020-08-09       Impact factor: 3.616

8.  In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome.

Authors:  Silva Hilburn; Aileen Rowan; Maria-Antonietta Demontis; Aidan MacNamara; Becca Asquith; Charles R M Bangham; Graham P Taylor
Journal:  J Infect Dis       Date:  2011-01-05       Impact factor: 5.226

Review 9.  The HBZ gene, a key player in HTLV-1 pathogenesis.

Authors:  Masao Matsuoka; Patrick L Green
Journal:  Retrovirology       Date:  2009-08-03       Impact factor: 4.602

Review 10.  Mechanisms of HTLV-1 persistence and transformation.

Authors:  M Boxus; L Willems
Journal:  Br J Cancer       Date:  2009-09-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.